Revenue grew 7% to $145M with record margins and EPS, driven by strong diversified end market growth. Full-year guidance was raised, with medical, industrial, and aerospace/defense segments all contributing, while transportation remains cautious amid macro uncertainties.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.